Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date | Reported DateTime | Company | Symbol | Insider Relationship | Shares Traded | Average Price | Total Amount | Shares Owned | Filing |
| 2022-06-16 Sale | 2022-06-21 4:37 pm | Deciphera Pharmaceuticals Inc. | DCPH | Sherman Matthew L EVP & Chief Medical Officer | 1,768 | $10.75 | $19,006 | 76,884 (Direct) | View |
| 2022-06-16 Sale | 2022-06-21 4:36 pm | Deciphera Pharmaceuticals Inc. | DCPH | Pitman Jama See Remarks | 1,298 | $10.75 | $13,954 | 36,661 (Direct) | View |
| 2022-06-16 Sale | 2022-06-21 4:35 pm | Deciphera Pharmaceuticals Inc. | DCPH | Martin Daniel C. Chief Commercial Officer | 1,311 | $10.75 | $14,093 | 49,521 (Direct) | View |
| 2022-06-16 Sale | 2022-06-21 4:35 pm | Deciphera Pharmaceuticals Inc. | DCPH | Kelly Thomas Patrick CFO | 1,768 | $10.75 | $19,006 | 46,080 (Direct) | View |
| 2022-06-16 Sale | 2022-06-21 4:34 pm | Deciphera Pharmaceuticals Inc. | DCPH | Flynn Daniel Lee Chief Scientific Officer | 1,768 | $10.75 | $19,006 | 367,553 (Indirect Direct) | View |
| 2022-04-29 Purchase | 2022-04-29 4:31 pm | Deciphera Pharmaceuticals Inc. | DCPH | Brightstar Associates LLC 10% Owner | 1,478,978 | $10 | $14,789,780 | 21,441,178 (Direct) | View |
| 2022-02-16 Sale | 2022-02-18 5:01 pm | Deciphera Pharmaceuticals Inc. | DCPH | Flynn Daniel Lee Chief Scientific Officer | 1,366 | $9.05 | $12,362 | 369,321 (Indirect Direct) | View |
| 2022-02-16 Sale | 2022-02-18 5:01 pm | Deciphera Pharmaceuticals Inc. | DCPH | Martin Daniel C. Chief Commercial Officer | 1,146 | $9.05 | $10,371 | 48,668 (Direct) | View |
| 2022-02-16 Sale | 2022-02-18 5:01 pm | Deciphera Pharmaceuticals Inc. | DCPH | Sherman Matthew L EVP & Chief Medical Officer | 984 | $9.05 | $8,905 | 76,790 (Direct) | View |
| 2022-02-16 Sale | 2022-02-18 5:01 pm | Deciphera Pharmaceuticals Inc. | DCPH | Kelly Thomas Patrick CFO | 1,368 | $9.05 | $12,380 | 47,848 (Direct) | View |
| 2022-02-16 Sale | 2022-02-18 5:00 pm | Deciphera Pharmaceuticals Inc. | DCPH | Pitman Jama See Remarks | 1,146 | $9.05 | $10,371 | 37,959 (Direct) | View |
| 2021-10-04 Sale | 2021-10-06 4:00 pm | Deciphera Pharmaceuticals Inc. | DCPH | Sherman Matthew L EVP & Chief Medical Officer | 2,659 | $33.17 | $88,199 | 46,029 (Direct) | View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
| 2022-06-23 Option Award | 2022-06-24 4:05 pm | N/A 2032-06-22 | Deciphera Pharmaceuticals Inc. | DCPH | Walsh Dennis Leo Director | 18,500 | $0 | 18,500 (Direct) | View |
| 2022-06-23 Option Award | 2022-06-24 4:05 pm | N/A 2032-06-22 | Deciphera Pharmaceuticals Inc. | DCPH | Bristol James Arthur Director | 18,500 | $0 | 18,500 (Direct) | View |
| 2022-06-23 Option Award | 2022-06-24 4:05 pm | N/A 2032-06-22 | Deciphera Pharmaceuticals Inc. | DCPH | Squarer Ron Director | 18,500 | $0 | 18,500 (Direct) | View |
| 2022-06-23 Option Award | 2022-06-24 4:05 pm | N/A 2032-06-22 | Deciphera Pharmaceuticals Inc. | DCPH | Martin John Richard Director | 18,500 | $0 | 18,500 (Direct) | View |
| 2022-06-23 Option Award | 2022-06-24 4:05 pm | N/A 2032-06-22 | Deciphera Pharmaceuticals Inc. | DCPH | Kelley Susan L. Director | 18,500 | $0 | 18,500 (Direct) | View |
| 2022-06-23 Option Award | 2022-06-24 4:05 pm | N/A 2032-06-22 | Deciphera Pharmaceuticals Inc. | DCPH | Benz Edward J. JR Director | 18,500 | $0 | 18,500 (Direct) | View |
| 2022-06-23 Option Award | 2022-06-24 4:05 pm | N/A 2032-06-22 | Deciphera Pharmaceuticals Inc. | DCPH | Allen Patricia L Director | 18,500 | $0 | 18,500 (Direct) | View |
| 2022-06-23 Option Award | 2022-06-24 4:05 pm | N/A 2032-06-22 | Deciphera Pharmaceuticals Inc. | DCPH | Friedman Franklin Stuart Director | 18,500 | $0 | 18,500 (Direct) | View |
| 2022-03-21 Tax Withholding | 2022-03-23 4:15 pm | N/A N/A | Deciphera Pharmaceuticals Inc. | DCPH | Hoerter Steven L. CEO | 3,150 | $9.11 | 37,545 (Direct) | View |
| 2022-01-18 Option Award | 2022-01-20 5:01 pm | N/A 2032-01-17 | Deciphera Pharmaceuticals Inc. | DCPH | Bristol James Arthur Director | 9,570 | $5.22 | 9,570 (Direct) | View |
| 2022-01-18 Option Award | 2022-01-20 5:01 pm | N/A 2032-01-17 | Deciphera Pharmaceuticals Inc. | DCPH | Walsh Dennis Leo Director | 9,570 | $5.22 | 9,570 (Direct) | View |
| 2022-01-18 Option Award | 2022-01-20 5:01 pm | N/A 2032-01-17 | Deciphera Pharmaceuticals Inc. | DCPH | Kelley Susan L. Director | 9,570 | $5.22 | 9,570 (Direct) | View |
| 2022-01-18 Option Award | 2022-01-20 5:01 pm | N/A 2032-01-17 | Deciphera Pharmaceuticals Inc. | DCPH | Squarer Ron Director | 9,570 | $5.22 | 9,570 (Direct) | View |
| 2022-01-18 Option Award | 2022-01-20 5:00 pm | N/A 2032-01-17 | Deciphera Pharmaceuticals Inc. | DCPH | Allen Patricia L Director | 9,570 | $5.22 | 9,570 (Direct) | View |
| 2022-01-18 Option Award | 2022-01-20 5:00 pm | N/A 2032-01-17 | Deciphera Pharmaceuticals Inc. | DCPH | Kelly Thomas Patrick CFO | 102,500 | $0 | 131,216 (Direct) | View |
| 2022-01-18 Option Award | 2022-01-20 5:00 pm | N/A 2032-01-17 | Deciphera Pharmaceuticals Inc. | DCPH | Friedman Franklin Stuart Director | 9,570 | $5.22 | 9,570 (Direct) | View |
| 2022-01-18 Option Award | 2022-01-20 5:00 pm | N/A 2032-01-17 | Deciphera Pharmaceuticals Inc. | DCPH | Martin Daniel C. Chief Commercial Officer | 68,334 | $0 | 104,481 (Direct) | View |
| 2022-01-18 Option Award | 2022-01-20 5:00 pm | N/A 2032-01-17 | Deciphera Pharmaceuticals Inc. | DCPH | Sherman Matthew L EVP & Chief Medical Officer | 102,500 | $0 | 159,774 (Direct) | View |
| 2022-01-18 Option Award | 2022-01-20 5:00 pm | N/A 2032-01-17 | Deciphera Pharmaceuticals Inc. | DCPH | Pitman Jama See Remarks | 68,334 | $0 | 93,772 (Direct) | View |
| 2022-01-18 Option Award | 2022-01-20 5:00 pm | N/A 2032-01-17 | Deciphera Pharmaceuticals Inc. | DCPH | Flynn Daniel Lee Chief Scientific Officer | 102,500 | $0 | 452,687 (Direct) | View |
| 2022-01-18 Option Award | 2022-01-20 5:00 pm | N/A 2032-01-17 | Deciphera Pharmaceuticals Inc. | DCPH | Hoerter Steven L. CEO | 415,000 | $0 | 415,000 (Direct) | View |
| 2021-12-15 Option Award | 2021-12-17 4:10 pm | N/A 2031-12-14 | Deciphera Pharmaceuticals Inc. | DCPH | Kelly Thomas Patrick CFO | 93,365 | $0 | 110,981 (Direct) | View |
| 2021-12-15 Option Award | 2021-12-17 4:10 pm | N/A 2031-12-14 | Deciphera Pharmaceuticals Inc. | DCPH | Pitman Jama See Remarks | 71,271 | $0 | 88,409 (Direct) | View |
| 2021-12-15 Option Award | 2021-12-17 4:10 pm | N/A 2031-12-14 | Deciphera Pharmaceuticals Inc. | DCPH | Hoerter Steven L. CEO | 270,357 | $0 | 311,052 (Direct) | View |
| 2021-12-15 Option Award | 2021-12-17 4:05 pm | N/A 2031-12-14 | Deciphera Pharmaceuticals Inc. | DCPH | Sherman Matthew L EVP & Chief Medical Officer | 93,365 | $0 | 139,539 (Direct) | View |
| 2021-12-15 Option Award | 2021-12-17 4:00 pm | N/A 2031-12-14 | Deciphera Pharmaceuticals Inc. | DCPH | Flynn Daniel Lee Chief Scientific Officer | 93,365 | $0 | 432,452 (Direct) | View |
| 2021-12-15 Option Award | 2021-12-17 4:00 pm | N/A 2031-12-14 | Deciphera Pharmaceuticals Inc. | DCPH | Martin Daniel C. Chief Commercial Officer | 71,271 | $0 | 99,118 (Direct) | View |
| 2021-06-23 Option Award | 2021-06-25 4:00 pm | N/A 2031-06-22 | Deciphera Pharmaceuticals Inc. | DCPH | Walsh Dennis Leo Director | 12,000 | $0 | 12,000 (Direct) | View |